NBP in Adult Patients With Acute Ischemic Stroke (AIS)

About this Trial

This is a Phase 2 multicenter, randomized, double-blind, placebo-controlled, add-on to standard of care study of NBP softgel capsules for the treatment of mild to moderate AIS in adults.

• Status: Enrolling now
• Location: Miami Valley Hospital
• Study type: Interventional
• Ages eligible for study: 18 to 85
• Genders eligible for study: Both
• Principal Investigator: John Terry, M.D.
• For more information about this study, visit ClinicalTrials.gov: NCT02905565

If you would like information about participating in this study, contact:

Contact Us

Angela Shoen
(937) 208-6013
angela.shoen@wright.edu
asshoen@premierhealth.com